Serial 98588346
Live / Allowed — Notice of allowance issued (as of 27 Jan 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 06 Jun 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98588346
- Mark type
- Design / logo
- Filed
- 06 Jun 2024
- Published for opposition
- 02 Dec 2025
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for use in the treatment of oncological, cardiological, dermatological, neurological, genetic, orthopedic and metabolic diseases and disorders
Owner
- Bridgebio Pharma, Inc., Palo Alto, CA, US
- Bridgebio Pharma, Inc., Palo Alto, CA, US
Prosecution history
- 27 Jan 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 02 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Dec 2025 — PUBLISHED FOR OPPOSITION
- 26 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 Nov 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 28 Mar 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 28 Mar 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 28 Mar 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 06 Jan 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 06 Jan 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 07 Oct 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 07 Oct 2024 — NON-FINAL ACTION E-MAILED
- 07 Oct 2024 — NON-FINAL ACTION WRITTEN
- 12 Sept 2024 — ASSIGNED TO EXAMINER
- 02 Jul 2024 — NOTICE OF DESIGN SEARCH CODE E-MAILED